Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium

por Feldman, Peter R., Feldman, Oriel J., Guevara-Aguirre, Jaime, Fiebig, Klaus M.
Publicado 2022

Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial

por Feldman, Peter R, Fiebig, Klaus M, Piwko, Charles, Mints, Boris M, Brown, Dennis, Cahan, Deborah J, Guevara-Aguirre, Jaime
Publicado 2021

Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial

por Feldman, Peter R, Fiebig, Klaus M, Piwko, Charles, Mints, Boris M, Brown, Dennis, Cahan, Deborah J, Guevara-Aguirre, Jaime
Publicado 2021

Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis

por Feldman, Peter R., Gentile, Pietro, Piwko, Charles, Motswaledi, Hendrik M., Gorun, Samantha, Pesachov, Jacob, Markel, Michael, Silver, Maxwell I., Brenkel, Megan, Feldman, Oriel J., Kamen, Corey L., Uleryk, Elizabeth, Guevara-Aguirre, Jaime, Fiebig, Klaus M.
Publicado 2023